STO:SUS
Surgical Science Sweden AB (publ) · STO · Healthcare · SEK · FY for 2025
Figures on this page computed 2026-11-08 12:57 UTC
Last close
n/aSEK
Market data
47.1xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
- Computed from the filing for 2025
1.9%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
6.7%Net margin
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
6.9%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.02Debt/equity
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- SEK
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth56.8%67 of 100, above its sector
- Returns on capital1.9%44 of 100, above its sector
- Margins58.1%67 of 100, above its sector
- Price47.1x46 of 100, above its sector
- Safety0.0282 of 100, above its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.